Reply to L. Cabel et al

J Clin Oncol. 2015 Jan 20;33(3):292-3. doi: 10.1200/JCO.2014.58.9671. Epub 2014 Dec 15.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / analysis*
  • Breast Neoplasms / chemistry*
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Neoplasm Recurrence, Local / chemistry*
  • Neoplasm Recurrence, Local / drug therapy*
  • Receptor, ErbB-2 / analysis*

Substances

  • Biomarkers, Tumor
  • Receptor, ErbB-2